Lakefront Biotherapeutics American Depositary Shares
LKFT
137 hedge funds and large institutions have $1.56B invested in Lakefront Biotherapeutics American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 40 increasing their positions, 39 reducing their positions, and 17 closing their positions.
159% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 17
23% more funds holding
Funds holding: 111 → 137 (+26)
21% more capital invested
Capital invested by funds: $1.29B → $1.56B (+$269M)
3% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 39
1.96% less ownership
Funds ownership: 13.65% → 11.69% (-2%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
49% less call options, than puts
Call options by funds: $21.6M | Put options by funds: $42.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Public Employees Retirement Association of Colorado
Denver,
Colorado
|
+$15.6M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$14.7M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$12M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.5M |
| 5 |
Barclays
London,
United Kingdom
|
+$8.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$46.6M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$27.9M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$22.6M |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$20.5M |
| 5 |
DM
Deerfield Management
New York
|
-$15.4M |
LKFT Hedge Fund Activity: Q4 2019 in Review
137 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q4 2019, worth a combined $1.56B — up 21% from $1.29B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new LKFT positions and 17 closed out — a net gain of 27 holders — while 40 added to existing stakes and 39 trimmed.
The largest buyer was Public Employees Retirement Association of Colorado, opening a new position worth an estimated $15.6M. The largest seller was BVF Inc, exiting entirely with an estimated $46.6M sold.
- 137 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q4 2019, up from 111 in Q3 2019.
- Funds reported $1.56B of Lakefront Biotherapeutics American Depositary Shares stock for Q4 2019, up 21% quarter-over-quarter.
- 44 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q4 2019 and 17 closed out, a net change of +27 holders.
- The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q4 2019 was Public Employees Retirement Association of Colorado, an estimated $15.6M added.
- The largest Lakefront Biotherapeutics American Depositary Shares seller in Q4 2019 was BVF Inc, an estimated $46.6M sold.
Based on aggregated 13F filings for Q4 2019.